Drugs / hTERT mRNA DC
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT01153113 | Jan 2008 → Dec 2009 | metastatic prostate carcinoma | University of Florida | Withdrawn | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | hTERT mRNA DC | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01153113 ↗ |
| Modality | Cell therapy | “hTERT mRNA-transfected dendritic cells (DC), applied in a prime-boost format” NCT01153113 ↗ |
| Route | Other | “administered ID” NCT01153113 ↗ |